| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7f6e33603375c486b0ab3505830af9e8 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-427
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-425 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-427
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-425 |
| filingDate |
1997-09-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3e1551cba1d2a0686c7b61bea20dd859
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e45fea8004992cca437dc36e3f8dcb8e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f1f31940a9a8b41a59a4ffb9522dff50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2836d611d8d3d0afb6e1758715cab7ed |
| publicationDate |
2001-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
NZ-334577-A |
| titleOfInvention |
Glutathione reductase activity potentiator containing troglitazone |
| abstract |
Described is the use of troglitazone or a pharmaceutically acceptable salt thereof in the manufacture of a medicament having activity in enhancing glutathione reductase activity for the prevention or treatment of diseases resulting from a deficiency of reduced glutathione, provided that said diseases do not include diabetes, hyperglycemia and complications thereof. |
| priorityDate |
1996-09-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |